Wardman, Jonathan H.
Andreassen, Søren Norge
Toft-Bertelsen, Trine L.
Jensen, Mette Nyholm
Wilhjelm, Jens E.
Styrishave, Bjarne
Hamann, Steffen
Heegaard, Steffen
Sinclair, Alexandra J.
MacAulay, Nanna http://orcid.org/0000-0002-7800-6600
Funding for this research was provided by:
Copenhagen University
Article History
Received: 20 October 2023
Accepted: 5 January 2024
First Online: 25 January 2024
Declarations
:
: Animal experiments were in compliance with the European Community Council Directive 2010/63/EU on the Protection of Animals used for Scientific Purposes. It was approved by the Danish Animal Experiments Inspectorate with permission no. 2018-15-0201-01515.
: Not applicable.
: AJS reports consulting fees and stockholding with Invex therapeutics, during the conduct of the study, she has also received personal fees for advisory board and lectures from Allergan, Amgen, Novartis and Cheisi on topics unrelated to the submitted work. The remaining authors declare that they have no competing interests.